Larson Financial Group’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
Larson Financial Group's HAE Position: Q3 2026 in Review
Larson Financial Group held its Haemonetics (HAE) position steady in Q3 2026 at 11 shares worth $1.16K. The position accounts for ﹤0.01% of the portfolio, ranked #3389.
Larson Financial Group first reported a position in HAE in Q1 2025 and has held it in 3 quarters since. The position peaked at $1.4K in Q1 2025. 361 funds tracked by Wall St. Rank hold HAE as of Q3 2026.
- Larson Financial Group held 11 shares of Haemonetics worth $1.16K as of Q3 2026.
- Larson Financial Group left its Haemonetics share count unchanged in Q3 2026.
- Haemonetics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3389 holding.
- Larson Financial Group first reported a position in Haemonetics in Q1 2025 and has held it in 3 quarters since.
- Larson Financial Group's Haemonetics position peaked at $1.4K in Q1 2025.
- 361 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.